Cellular Therapy in Oncology Pipeline Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

Cellular Therapy in Oncology Pipeline Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017 - 2025

  • Transparency Market Research
  • Ongoing
  • Pharmaceutical

Report Description

1
1

Cellular therapy, also known as cytotherapy, is a therapy in which cellular material is injected into a patient. For example, T cells, capable of showing a cell mediated immune response, are injected into a cancer patient during immunotherapy. Cellular therapy is used in the treatment of different types of disorders and diseases. The main approach for cellular therapy in oncology involves infusion of immune cells either to replace most of the patient’s immune system to enhance his immune response to cancer or to activate his cell mediated immune system to kill the cancer cells, or to directly find and kill the targeted cancer cells. Presently, multiple cell-based approaches are ongoing in clinical phase I through phase III testing in patients diagnosed with different types of cancer.

According to the World Health Organization (WHO), around 8.2 million people die annually from cancer, worldwide. Rise in the prevalence rate of cancer due to lack of adequate treatment is the major reason fuelling the growth of the global cellular therapy in oncology pipeline market. Cell therapy trials are presently ongoing which are in various phases. Cellular therapy is said to have advantage over gene therapy; recently, scientists have developed innovative therapies by combining both cell and gene therapies. Moreover, dendritic cell therapy is another promising development in the treatment of cancer. These are some of the drivers of the global cellular therapy in oncology pipeline market during the forecast period. Recently developed immunotherapies representing a variety of mechanisms of actions, such as novel agents targeting proteins or cell surface markers, are in the phase of clinical trials, is another factor that is expected to propel the growth of the global cellular therapy in oncology pipeline market during the forecast period. However, high cost of therapies, development of biosimilars and drugs for prevention and treatment of cancer, and stringent regulatory scenario are anticipated to be the key restraints to the growth of the global cellular therapy in oncology pipeline market during the forecast period. 

The global cellular therapy in oncology pipeline market can be segmented on the basis of clinical phase, type of mechanism of action, and geography. The global cellular therapy market, based on clinical phase, can be divided into research, preclinical, clinical phase I, clinical phase I/II, clinical phase II, and clinical phase III. In terms of type of mechanism of action, the global cellular therapy in oncology pipeline market can be classified into targeting signaling pathways, targeting cell surface markers, targeting miRNA expression, and others. Targeting the signaling pathway is a promising mechanism and is expected to register high growth in the global cellular therapy in oncology pipeline market.

Geographically, the global cellular therapy in oncology pipeline market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global cellular therapy in oncology pipeline market during the forecast period owing to developed research infrastructure, high prevalence of cancer, strong funding for oncology research, etc. Asia Pacific is anticipated to exhibit significant growth in the global cellular therapy in oncology pipeline market due to the factors such as developing research domain, rise in awareness among people regarding treatment of cancer, and high prevalence of cancer on the region.

Major global players operating in the global cellular therapy in oncology pipeline market include Aldagen, apceth Biopharma GmbH, Benitec Biopharma Limited, Argos Therapeutics, CELGENE CORPORATION, Immunocellular Therapeutics, Ltd, GALENA BIOPHARMA, pluristem Commence Bio, and Kite Pharma. To sustain a significant position in the global cellular therapy in oncology pipeline market, these players have been adopting strategies such as developing highly efficient and cost-effective products. Recently, certain companies have also developed a sophisticated automated device for cell expansion and culture processing which can be used in the treatment of different types of cancer.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Have query on this report?

Make an Enquiry

Success Stories

Our Clients